Related Experiment Videos
Toxicity study of BCNU (NSC-409962) given orally
Cancer Chemotherapy Reports
|May 1, 1974
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivo.
Cancer investigation·1998
Response of human multiple myeloma-derived cell lines to alkyl-lysophospholipid.
Experimental hematology·1996
A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow.
Advances in experimental medicine and biology·1996
Urinary excretion of polyamines by patients with advanced malignancy.
Cancer chemotherapy reports·1975
Chemotherapy of transplanted adenocarcinomas of the colon in mice.
Cancer chemotherapy reports·1975
Tissue disposition of 3H-actinomycin D (NSC-3053) in the rat, monkey, and dog.
Cancer chemotherapy reports·1975
Toxicology studies with cytembena (NSC-104801), an antineoplastic agent with a multispecies nephrotoxic effect.
Cancer chemotherapy reports·1975
Phase I study of corynebacterium parvum in patients with solid tumors.
Cancer chemotherapy reports·1975
Combination chemotherapy for acute nonlymphoblastic leukemia in adults.
Cancer chemotherapy reports·1975